"Fibromatosis, Aggressive" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A childhood counterpart of abdominal or extra-abdominal desmoid tumors, characterized by firm subcutaneous nodules that grow rapidly in any part of the body but do not metastasize. The adult form of abdominal fibromatosis is FIBROMATOSIS, ABDOMINAL. (Stedman, 25th ed)
| Descriptor ID |
D018222
|
| MeSH Number(s) |
C04.557.450.565.590.340.410
|
| Concept/Terms |
Fibromatosis, Aggressive- Fibromatosis, Aggressive
- Aggressive Fibromatoses
- Aggressive Fibromatosis
- Fibromatoses, Aggressive
- Desmoid
- Desmoids
|
Below are MeSH descriptors whose meaning is more general than "Fibromatosis, Aggressive".
Below are MeSH descriptors whose meaning is more specific than "Fibromatosis, Aggressive".
This graph shows the total number of publications written about "Fibromatosis, Aggressive" by people in this website by year, and whether "Fibromatosis, Aggressive" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 2 | 0 | 2 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 1 | 2 |
| 2004 | 1 | 0 | 1 |
| 2005 | 3 | 0 | 3 |
| 2006 | 2 | 0 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 3 | 1 | 4 |
| 2009 | 1 | 0 | 1 |
| 2010 | 1 | 0 | 1 |
| 2011 | 4 | 0 | 4 |
| 2012 | 2 | 0 | 2 |
| 2013 | 2 | 0 | 2 |
| 2014 | 0 | 1 | 1 |
| 2015 | 3 | 0 | 3 |
| 2018 | 2 | 0 | 2 |
| 2019 | 1 | 1 | 2 |
| 2020 | 1 | 0 | 1 |
| 2021 | 3 | 0 | 3 |
| 2022 | 1 | 0 | 1 |
| 2023 | 3 | 0 | 3 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Fibromatosis, Aggressive" by people in Profiles.
-
Current Management of Desmoid Tumors: A Review. JAMA Oncol. 2024 Aug 01; 10(8):1121-1128.
-
Is it possible to establish a calculable causal relationship between trauma and sporadic desmoid tumors? Cancer. 2024 01 01; 130(1):16-17.
-
Maintaining Health-related Quality of Life for Desmoid Tumor Patients: The Proof is in the Data. Ann Surg. 2023 06 01; 277(6):884-885.
-
Nirogacestat, a ?-Secretase Inhibitor for Desmoid Tumors. N Engl J Med. 2023 Mar 09; 388(10):898-912.
-
Systemic Chemotherapies Retain Antitumor Activity in Desmoid Tumors Independent of Specific Mutations in CTNNB1 or APC: A Multi-institutional Retrospective Study. Clin Cancer Res. 2022 09 15; 28(18):4092-4104.
-
Incidental 18F-Fluciclovine Uptake in a Desmoid Tumor Detected in a Patient Undergoing PET/CT Imaging for Prostate Cancer. Clin Nucl Med. 2021 Apr 01; 46(4):355-357.
-
Desmoid Fibromatosis: Management in an Era of Increasing Options. Curr Oncol Rep. 2021 03 14; 23(4):41.
-
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Epidemiology, Diagnosis, Staging, and Histology-Specific Management Considerations. Am Soc Clin Oncol Educ Book. 2021 Mar; 41:390-404.
-
Certain risk factors for patients with desmoid tumors warrant reconsideration of local therapy strategies. Cancer. 2020 07 15; 126(14):3265-3273.
-
Management and outcomes of ruptured, perforated or fistulized tumors of mesenchymal origin. J Surg Oncol. 2020 Mar; 121(3):474-479.